Trials / Unknown
UnknownNCT01835613
Evaluation Effects of Treatment With IL-6R Inhibitor on Clinical Response and Biomarkers in Patients With Rheumatoid Arthritis (RA) Not Responding to DMARDs and/or a First Biological Agent.
- Status
- Unknown
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 150 (estimated)
- Sponsor
- Osservatorio Epidemiologico GISEA · Academic / Other
- Sex
- All
- Age
- 18 Years – 75 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to assess the clinical response to IL-6 inhibition defined as Low Disease Activity (DAS44) \<2.4) at the follow-up visit at 12 months and the correlation between the biomarkers and treatment response.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | Biomarkers Measures | At the routine visits (0, 3, 6, 12 and 18 months), a clinical evaluation will be made and samples collected for assaying the biomarkers. |
Timeline
- Start date
- 2013-01-01
- Primary completion
- 2015-07-01
- Completion
- 2015-12-01
- First posted
- 2013-04-19
- Last updated
- 2013-04-19
Locations
1 site across 1 country: Italy
Source: ClinicalTrials.gov record NCT01835613. Inclusion in this directory is not an endorsement.